Literature DB >> 29434497

Cerebellar Ganglioglioma in Childhood: Histopathologic Implications for Management During Long-term Survival: A Case Report.

Koyo Ohno1, Yoshiaki Saito1, Akiko Tamasaki-Kondo1, Atsushi Kambe2, Yasushi Horie3, Shinsuke Kato4, Yoshihiro Maegaki1.   

Abstract

We report the case of a 19-year-old female with cerebellar ganglioglioma that was diagnosed at 4 years of age. Despite treatment with partial resection, radiation, and chemotherapy, residual tumor slowly expanded into the brainstem and upper cervical cord, resulting in nocturnal hypopnea, progressive tetraparesis, and feeding difficulty during 8-10 years of age. Initiation of temozolomide and bevacizumab was effective in preventing further expansion of the tumor, and the patient has been treated at home and in school with noninvasive positive pressure ventilation and gastrostomy. Histopathologic examination of the resected tumor tissue revealed phospho-S6-positive tumor cells of either neuronal or astroglial appearance. This suggests that a higher proportion of cells of glial lineage could be linked to the progression of cerebellar ganglioglioma in childhood. Possible treatment options with mammalian target of rapamycin inhibitors are discussed.

Entities:  

Keywords:  Lhermitte–Duclos disease; PTEN; childhood cerebellar tumor; mTOR

Year:  2018        PMID: 29434497      PMCID: PMC5803164          DOI: 10.24563/yam.2017.12.008

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  12 in total

1.  mTORC1 activation in childhood ependymoma and response to sirolimus.

Authors:  Daniel C Bowers; Blanka Kucejova; Linda Margraf; Lynn Gargan; James Brugarolas
Journal:  J Neurooncol       Date:  2010-11-13       Impact factor: 4.130

2.  Differential cellular gene expression in ganglioglioma.

Authors:  Uzma Samadani; Alexander R Judkins; Albert Akpalu; Eleonora Aronica; Peter B Crino
Journal:  Epilepsia       Date:  2007-04       Impact factor: 5.864

Review 3.  Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.

Authors:  Ty W Abel; Suzanne J Baker; Melissa M Fraser; Tarik Tihan; James S Nelson; Anthony T Yachnis; John-Paul Bouffard; Hernando Mena; Peter C Burger; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2005-04       Impact factor: 3.685

4.  Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma.

Authors:  Marc Zanello; Mélanie Pages; Arnault Tauziède-Espariat; Raphael Saffroy; Stéphanie Puget; Ludovic Lacroix; Edouard Dezamis; Bertrand Devaux; Fabrice Chrétien; Felipe Andreiuolo; Christian Sainte-Rose; Michel Zerah; Frédéric Dhermain; Sarah Dumont; Guillaume Louvel; Jean-François Meder; Jacques Grill; Christelle Dufour; Johan Pallud; Pascale Varlet
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-18       Impact factor: 3.685

5.  PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.

Authors:  Sabine Mueller; Joanna Phillips; Arzu Onar-Thomas; Eloy Romero; Shichun Zheng; John K Wiencke; Sean M McBride; Cynthia Cowdrey; Michael D Prados; William A Weiss; Mitchel S Berger; Nalin Gupta; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

6.  Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report.

Authors:  Hidehiro Takei; Robert Dauser; Jack Su; Murali Chintagumpala; Meenakshi B Bhattacharjee; Jeremy Jones; Adekunle M Adesina
Journal:  J Neurosurg       Date:  2007-08       Impact factor: 5.115

7.  Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.

Authors:  Xiao-Ping Zhou; Deborah J Marsh; Carl D Morrison; Abhik R Chaudhury; Marius Maxwell; Guido Reifenberger; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

8.  Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.

Authors:  Karin Boer; Dirk Troost; Wendy Timmermans; Peter C van Rijen; Wim G M Spliet; Eleonora Aronica
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

9.  Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH.

Authors:  Alexander Hoischen; Marion Ehrler; Jana Fassunke; Matthias Simon; Michael Baudis; Christina Landwehr; Bernhard Radlwimmer; Peter Lichter; Johannes Schramm; Albert J Becker; Ruthild G Weber
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

10.  Upregulation of mitogen-activated protein kinase in ganglioglioma.

Authors:  Beata Rak; Stanisław Szlufik; Wiesława Grajkowska; Danuta Perek; Bożena Dembowska-Bagińska; Iwona Filipek; Paweł Daszkiewicz; Paweł Włodarski; Jarosław Jóźwiak
Journal:  Folia Neuropathol       Date:  2013       Impact factor: 2.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.